LivaNova picks longtime J&J exec as CEO; 3M could reportedly raise up to $12B from spinoff

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 6, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Procyrion raised $57.7 million in a Series E funding round for its circulatory support device. Fast Five hosts Danielle Kirsh and Sean Whooley talk about what the funding will support, what its Aortix device is and what executives have to say about the funding raise. Biosense Webster released positive Varipulse pulsed field ablation data. Whooley details which data points stuck out in the InspIRE and AdmIRE studies.  Carthera enrolled its first patients in an ultrasound drug delivery trial. Learn how the ultrasound drug delivery technology works and what the trial will evaluate. 3M could reportedly raise up to $12 billion from its Solventum spinoff. Hear more about what the money raise could be used for and the current status of the spinoff.  LivaNova has picked a longtime J&J executive as its new CEO. The Fast Five hosts share who is joining the company, their career history and the optimism he brings to the company.  BONUS: Read more from Whooley's discussion with ReWalk Robotics' CEO as the company looks ahead following its Lifeward rebrand.